Literature DB >> 18830418

Molecular processes that handle -- and mishandle -- dietary lipids.

Kevin Jon Williams1.   

Abstract

Overconsumption of lipid-rich diets, in conjunction with physical inactivity, disables and kills staggering numbers of people worldwide. Recent advances in our molecular understanding of cholesterol and triglyceride transport from the small intestine to the rest of the body provide a detailed picture of the fed/fasted and active/sedentary states. Key surprises include the unexpected nature of many pivotal molecular mediators, as well as their dysregulation - but possible reversibility - in obesity, diabetes, inactivity, and related conditions. These mechanistic insights provide new opportunities to correct dyslipoproteinemia, accelerated atherosclerosis, insulin resistance, and other deadly sequelae of overnutrition and underexertion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830418      PMCID: PMC2556568          DOI: 10.1172/JCI35206

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  127 in total

Review 1.  The discovery of ezetimibe: a view from outside the receptor.

Authors:  John W Clader
Journal:  J Med Chem       Date:  2004-01-01       Impact factor: 7.446

2.  Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.

Authors:  Scott W Altmann; Harry R Davis; Li-Ji Zhu; Xiaorui Yao; Lizbeth M Hoos; Glen Tetzloff; Sai Prasad N Iyer; Maureen Maguire; Andrei Golovko; Ming Zeng; Luquan Wang; Nicholas Murgolo; Michael P Graziano
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

3.  Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor.

Authors:  Andrew M Anisfeld; Heidi R Kast-Woelbern; Marie E Meyer; Stacey A Jones; Yanqiao Zhang; Kevin J Williams; Timothy Willson; Peter A Edwards
Journal:  J Biol Chem       Date:  2003-03-26       Impact factor: 5.157

4.  Glypican-1 is a vehicle for polyamine uptake in mammalian cells: a pivital role for nitrosothiol-derived nitric oxide.

Authors:  Mattias Belting; Katrin Mani; Mats Jönsson; Fang Cheng; Staffan Sandgren; Susanne Jonsson; Kan Ding; Jean-Guy Delcros; Lars-Ake Fransson
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

Review 5.  The role of intramuscular lipid in insulin resistance.

Authors:  B D Hegarty; S M Furler; J Ye; G J Cooney; E W Kraegen
Journal:  Acta Physiol Scand       Date:  2003-08

6.  ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion.

Authors:  Gregory A Graf; Liqing Yu; Wei-Ping Li; Robert Gerard; Pamela L Tuma; Jonathan C Cohen; Helen H Hobbs
Journal:  J Biol Chem       Date:  2003-09-22       Impact factor: 5.157

7.  Apolipoprotein B100 exit from the endoplasmic reticulum (ER) is COPII-dependent, and its lipidation to very low density lipoprotein occurs post-ER.

Authors:  Viktoria Gusarova; Jeffrey L Brodsky; Edward A Fisher
Journal:  J Biol Chem       Date:  2003-09-05       Impact factor: 5.157

8.  Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders.

Authors:  Bethan Jones; Emma L Jones; Stephanie A Bonney; Hetal N Patel; Arjen R Mensenkamp; Sophie Eichenbaum-Voline; Mats Rudling; Urban Myrdal; Grazia Annesi; Sandhia Naik; Nigel Meadows; Aldo Quattrone; Suhail A Islam; Rossitza P Naoumova; Bo Angelin; Recaredo Infante; Emile Levy; Claude C Roy; Paul S Freemont; James Scott; Carol C Shoulders
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

9.  Glucose regulates the expression of the farnesoid X receptor in liver.

Authors:  Daniel Duran-Sandoval; Gisèle Mautino; Geneviève Martin; Fréderic Percevault; Olivier Barbier; Jean-Charles Fruchart; Folkert Kuipers; Bart Staels
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

10.  Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8.

Authors:  Liqing Yu; Jennifer York; Klaus von Bergmann; Dieter Lutjohann; Jonathan C Cohen; Helen H Hobbs
Journal:  J Biol Chem       Date:  2003-02-22       Impact factor: 5.157

View more
  55 in total

1.  Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemia.

Authors:  H Carlijne Hassing; Hans Mooij; Shuling Guo; Brett P Monia; Keyang Chen; Wim Kulik; Geesje M Dallinga-Thie; Max Nieuwdorp; Erik S G Stroes; Kevin Jon Williams
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

2.  FoxO1 and hepatic lipid metabolism.

Authors:  Janet D Sparks; Henry H Dong
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

3.  Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins.

Authors:  Keyang Chen; Ming-Lin Liu; Lana Schaffer; Mingzhen Li; Guenther Boden; Xiangdong Wu; Kevin Jon Williams
Journal:  Hepatology       Date:  2010-11-03       Impact factor: 17.425

4.  Bringing retinoid metabolism into the 21st century.

Authors:  Theo J C van Berkel
Journal:  J Lipid Res       Date:  2009-09-25       Impact factor: 5.922

5.  The ER-associated degradation adaptor protein Sel1L regulates LPL secretion and lipid metabolism.

Authors:  Haibo Sha; Shengyi Sun; Adam B Francisco; Nicole Ehrhardt; Zhen Xue; Lei Liu; Peter Lawrence; Frits Mattijssen; Robert D Guber; Muhammad S Panhwar; J Thomas Brenna; Hang Shi; Bingzhong Xue; Sander Kersten; André Bensadoun; Miklós Péterfy; Qiaoming Long; Ling Qi
Journal:  Cell Metab       Date:  2014-07-24       Impact factor: 27.287

6.  Regulating intestinal function to reduce atherogenic lipoproteins.

Authors:  M Mahmood Hussain; Tung Ming Leung; Liye Zhou; Sarah Abu-Merhi
Journal:  Clin Lipidol       Date:  2013-08-01

7.  Globular warming: how fat gets to the furnace.

Authors:  Kevin Jon Williams; Edward A Fisher
Journal:  Nat Med       Date:  2011-02       Impact factor: 53.440

Review 8.  Intestinal lipid absorption and lipoprotein formation.

Authors:  M Mahmood Hussain
Journal:  Curr Opin Lipidol       Date:  2014-06       Impact factor: 4.776

Review 9.  Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies.

Authors:  Janine J Geerling; Mariëtte R Boon; Sander Kooijman; Edwin T Parlevliet; Louis M Havekes; Johannes A Romijn; Illiana M Meurs; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2013-11-27       Impact factor: 5.922

10.  Nitric oxide-releasing agent, LA419, reduces atherogenesis in apolipoprotein E-deficient mice.

Authors:  Ricardo Carnicer; Natalia Guillén; José M Arbonés-Mainar; María A Navarro; Mario A Guzmán; Cristina Barranquero; Carmen Arnal; Sonia Gascón; Sergio Acín; Marisabel Mourelle; Jesús Osada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-12-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.